Dr. Philip Seo is an Associate Professor in the Division of Rheumatology. A graduate of Harvard College and the College of Physicians and Surgeons at Columbia University, Dr. Seo completed his Internal Medicine training as a member of the Osler Medical Service at the Johns Hopkins Hospital. Since then, he has worked at Johns Hopkins in several capacities, including as a hospitalist at Johns Hopkins Bayview Medical Center, and as an Assistant Chief of Service of the Department of Medicine at the Johns Hopkins Hospital, before joining the Division of Rheumatology. Dr. Seo is the Director of the Johns Hopkins Vasculitis Center and Director of the Johns Hopkins Rheumatology Fellowship Program. His clinical interests lie in the assessment and treatment of patients with systemic vasculitis, in particular, the ANCA-associated vasculitides, which include granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis. Dr. Seo is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy. Dr. Seo is board certified in American Board Of Internal Medicine.

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Paik is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Polymyositis, Myositis, and Scleroderma. Dr. Paik is board certified in American Board Of Internal Medicine.

Dr. Alan Baer graduated from the Johns Hopkins University School of Medicine in 1978 and completed his post-graduate medical training in Internal Medicine and Rheumatology at the Johns Hopkins and Vanderbilt University Hospitals. He was a faculty member at the University at Buffalo, State University of New York, from 1986 to 2007, and served there as Chief of the Section of Rheumatology and Fellowship Program Director. He joined the faculty at Johns Hopkins in 2007 and is currently Professor of Medicine and Director of the Jerome L. Greene Sjogren's Syndrome Center. Since 2015, he has been an Investigator in the Sjogren's Syndrome Clinic at the National Institutes of Health. He was Chief of Rheumatology and Clinical Director of the Johns Hopkins University Rheumatology Practice at the Good Samaritan Hospital in Baltimore, Maryland from 2007 to 2014. Dr. Baer is currently engaged in a number of research studies in the area of Sjogren's syndrome, both at Johns Hopkins and in the NIH Sjogren's Syndrome Clinic. He was the principal investigator of the NIH subcontract to Johns Hopkins to conduct the Sjogren's International Registry (SICCA) and enrolled 300 patients into the registry. The SICCA registry has been a rich source of clinical data and biospecimens for research that Dr. Baer is conducting with colleagues at both Hopkins and the University of California-San Francisco. He is conducting a longitudinal observational study of patients with Sjogren's syndrome. Dr. Baer is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis. Dr. Baer is board certified in American Board Of Internal Medicine.

Dr. Christopher-Stine is the Co-Founder and Director of the Johns Hopkins Myositis Center. She is a Professor of Medicine and Neurology. She is a longstanding core faculty member of the Johns Hopkins University School of Medicine College Advisory Program and serves as the Co-Chair of the Johns Hopkins Institutional Review Board (IRB 5). Dr. Christopher-Stine graduated Cum Laude with a B.A. in chemistry from Franklin and Marshall College; was elected to Alpha Omega Alpha at Hahnemann University School of Medicine, where she received her MD degree, and she attained her Masters of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Her internship and residency training were completed at MCP Hahnemann University, where she also served as Chief Resident. She pursued her rheumatology fellowship training at Johns Hopkins. Dr. Christopher is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Myositis, Polymyositis, Dermatomyositis, and Inclusion Body Myositis. Dr. Christopher is board certified in American Board Of Internal Medicine.

Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. Dr. Petri is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Tenotomy, and Osteotomy. Dr. Petri is board certified in American Board Of Internal Medicine and American Board Of Allergy And Immunology.

Dr. Christopher A. Mecoli is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is rheumatology. A physician-scientist, Dr. Mecoli serves on the faculty of Johns Hopkins Myositis Center and Johns Hopkins Scleroderma Center. He earned his M.D. from Rutgers New Jersey Medical School. He completed an internal medicine residency at the Hospital of the University of Pennsylvania and a rheumatology fellowship at Johns Hopkins. He also holds an M.H.S. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Mecoli is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Dermatomyositis, Myositis, Polymyositis, and Scleroderma.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma. Dr. Hummers is board certified in American Board Of Internal Medicine.

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma. Dr. Wigley is board certified in American Board Of Internal Medicine.

Dr. Ana-Maria Orbai is an Associate Professor of Medicine in the Division of Rheumatology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and psoriatic arthritis. Dr. Orbai earned her M.D. from the Iuliu Hatieganu School of Medicine and Pharmacy, Cluj-Napoca, in Romania. She completed internship and residency training in internal medicine at the Johns Hopkins University-Sinai Hospital program. Subsequently, Dr. Orbai completed her post-doctoral fellowship training in rheumatology at Johns Hopkins. During her fellowship she earned her Master in Health Sciences degree in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Orbai directs the Psoriatic Arthritis Program in the Johns Hopkins Arthritis Center. Her clinical focus is psoriatic arthritis and spodyloarthritis. Dr. Orbai's research aims to understand psoriatic disease subtypes and improve treatment strategies for people with psoriatic arthritis. Dr. Orbai was awarded a Rheumatology Research Foundation Scientist Development award in 2014 and a Jerome L Greene Foundation Scholar award in 2018. Dr. Orbai is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Psoriatic Arthritis, Psoriasis, Arthritis, and Rheumatoid Arthritis (RA). Dr. Orbai is board certified in American Board Of Internal Medicine.

Andrea Fava is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Fava is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Scleroderma, and Systemic Sclerosis (SSc). Dr. Fava is board certified in American Board Of Internal Medicine.

Dr. John Aucott is an associate professor of medicine at the Johns Hopkins University School of Medicine. An internist and Lyme disease expert in the Division of Rheumatology, he is the director of the Johns Hopkins Lyme Disease Clinical Research Center. With more than 15 years of research experience on the crippling effects of Lyme disease, he has published studies focusing on characteristics of early Lyme disease differences in males and females with an emphasis on prospects for prevention, diagnosis and treatment. Dr. Aucott received his medical degree from the Johns Hopkins University School of Medicine. He completed his residency in internal medicine at the University Hospitals of Cleveland. He is fellowship-trained in infectious disease and geographic medicine. Dr. Aucott and his colleagues were recognized by Johns Hopkins with a Discovery Fund Synergy Award in 2014. Dr. Aucott is highly rated in 1 condition, according to our data. His clinical expertise encompasses Lyme Disease, Synovitis, Reactive Arthritis, and Long Haul COVID. Dr. Aucott is board certified in American Board Of Internal Medicine.

Dean Metcalfe is a Rheumatologist practicing medicine in Bethesda, Maryland. Dr. Metcalfe is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Mast Cell Activation Syndrome (MCAS), Systemic Mastocytosis, Urticaria Pigmentosa, and Anaphylaxis.

Dr. Grader-Beck is an Associate Professor of Clinical Medicine in the Rheumatology Division. Dr. Grader-Beck’s clinical expertise includes the diagnosis and treatment of Sjogren's syndrome as well as inflammatory arthritis. He has a specific interest in improving quality of patient care and clinical research using state of the art information technology. He is developing innovative ways in how clinicians and researchers can leverage electronic health record systems to deliver individualized patient care and precision medicine. Dr. Grader is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Sjogren Syndrome, Rheumatoid Arthritis (RA), Interstitial Keratitis, and Dermatomyositis. Dr. Grader is board certified in American Board Of Preventive Medicine and American Board Of Internal Medicine.

Marcela Ferrada is a Rheumatologist practicing medicine in Baltimore, Maryland. Dr. Ferrada is highly rated in 1 condition, according to our data. Her clinical expertise encompasses MAGIC Syndrome, Chickenpox, Subglottic Stenosis, and Shingles.

Dr. Thomas is a native of Ellicott City, MD, and attended the University of Maryland where she earned her B.S. with majors in Neurobiology and Physiology. Afterwards she graduated from the Pennsylvania State University College of Medicine in Hershey, Pennsylvania, and then completed her Internal Medicine Residency and Rheumatology Fellowship at Georgetown University Hospital in Washington, DC.Dr. Thomas has received multiple scholarships and awards throughout her academic and medical careers, was elected to the Alpha Omega Alpha Honors Society in November 2008, and was awarded the William P. Argy Teaching Resident Award in 2011. Dr. Thomas has been named a “Top Doctor” by Washingtonian Magazine for multiple consecutive years, as well as by Arlington Magazine and Northern Virginia Magazine. She has co-authored several articles and abstracts, presented research on Systemic Sclerosis at the American College of Rheumatology national meeting in Chicago in November 2011, and is the first author of a manuscript on tuberculous arthritis that has recently been accepted for publication.Dr. Thomas is Board Certified in Internal Medicine and Rheumatology and is a member of the American College of Rheumatology. Her areas of interest include systemic lupus erythematosus, rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, and ankylosing spondylitis. Dr. Saddic is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Rheumatoid Arthritis (RA), and Ankylosing Spondylitis. Dr. Saddic is board certified in Rheumatology.

Dr. Louie earned his B.A. degree in Molecular and Cell Biology at the University of California at Berkeley. He graduated medical school from Drexel University (formerly known as MCP Hahnemann University) in Philadelphia and completed his internship and residency in internal medicine at California Pacific Medical Center in San Francisco. He subsequently completed a fellowship in rheumatology at the National Institutes of Health in Bethesda. Additional training in clinical investigation at Duke University School of Medicine earned him a master's in health sciences degree.Dr. Louie served as Assistant Professor of Medicine in the division of rheumatology at Johns Hopkins University School of Medicine for 6 years. There, he relished his role as a preceptor for trainees in the classroom, ambulatory and inpatient settings. Dr. Louie has published numerous articles in peer reviewed medical journals and has presented at local and national scientific meetings. He has also served as principal investigator and co-investigator in various clinical trials of new arthritis therapies. After leaving Hopkins, Dr. Louie worked in a private practice before joining ARA.Dr. Louie treats all manner of rheumatological conditions, but has particular interest and expertise in inflammatory arthritis, including axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis. Dr. Louie is an active member of SPARTAN, a professional organization of North American experts in spondyloarthritis. Dr. Louie is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Ankylosing Spondylitis, Osteoporosis, and Psoriasis. Dr. Louie is board certified in Rheumatology and Internal Medicine.

Dr. Berhanu was born and raised in Denver, Colorado. She attended Stanford University where she earned a B.A. degree in human biology. She earned her medical degree from the University of Illinois School of Medicine and completed her residency in internal medicine at Loyola University in Chicago. She completed her fellowship in rheumatology at New York University’s Langone Medical Center where she served as chief fellow in her final year. Following her fellowship, Dr. Berhanu joined the medical faculty at George Washington University as Assistant Professor of Rheumatology where she had an active clinical practice and trained new physicians.Dr. Berhanu has a clinical interest in musculoskeletal ultrasound for which she received specialized training from USSONAR and obtained RhMSUS certification from the American College of Rheumatology. She applies her expertise with musculoskeletal ultrasound to her clinical interest in gout and has authored or co-authored several articles on the therapeutic management of gout. In addition to her research interests, Dr. Berhanu has long been dedicated to community service, both locally and abroad. She served as the 2018 Arthritis Foundation “Walk to Cure Arthritis” Medical Honoree and is particularly proud to have worked with the rheumatology program at the teaching hospital in Addis Ababa, Ethiopia. Dr. Berhanu is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Tenosynovitis, and Gout. Dr. Berhanu is board certified in Rheumatology and Internal Medicine.

Dr. Kumar earned her undergraduate degree in neurobiology and physiology at the University of Maryland, College Park. She completed her medical degree at St. George’s University, where she was a member of the Iota Epsilon Alpha medical honor society. She completed her internal medicine residency at Rutgers New Jersey School of Medicine and her fellowship training in rheumatology at the Ochsner Clinic Foundation in New Orleans, Louisiana.During her fellowship, Dr. Kumar participated in a wide range of clinical and translational research projects which have been recognized by the American College of Rheumatology, Rheumatology Alliance of Louisiana, Congress of Clinical Rheumatology, and the North American Young Rheumatology Investigator Forum. Her work has been published in journals such as The Rheumatologist and Healio Rheumatology. She is actively involved in applications of diagnostic and interventional musculoskeletal ultrasound in rheumatology. Along with cortisone and hyaluronic acid injections, Dr. Kumar is trained in performing Iovera procedures, a cryotherapy option to treat knee pain. She believes in a comprehensive and collaborative approach to patient care.Dr. Kumar is board certified in internal medicine and rheumatology. She is also a certified clinical densitometrist. She is a member of the American College of Rheumatology, the American Medical Association, the International Society for Clinical Densitometry, and the Association of Women in Rheumatology. Dr. Kumar is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Postmenopausal Osteoporosis, Osteoporosis, Rheumatoid Arthritis (RA), and Juvenile Primary Osteoporosis. Dr. Kumar is board certified in Rheumatology.

Dr. Hellmann is one of Johns Hopkins best physicians, teachers, and program builders. He holds the Aliki Perroti endowed Chair, recognizing his leadership in education. Dr. Hellmann’s clinical care and research focus is on vasculitis. Over the last four years, Dr. Hellmann has evaluated over 200 patients with systemic vasculitis. Areas of interest have included granulomatosis with polyangiitis, temporal arteritis, Takayasu’s arteritis, and polyarteritis nodosa. Dr. Hellmann is director of the Johns Hopkins Center for Innovative Medicine which promotes patient-centered care through the creative collaboration of research, teaching, and patient care programs. Dr. Hellmann is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Behcet Disease, Necrotizing Vasculitis, Takayasu Arteritis, and Juvenile Temporal Arteritis. Dr. Hellmann is board certified in American Board Of Internal Medicine.

Dr. Antiochos sees patients in the Division of Rheumatology on the Bayview campus and conducts basic science research into the pathogenesis of rheumatic diseases in the Division's laboratory. Lab website: Brendan Antiochos MD. Dr. Antiochos is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Granulomatosis with Polyangiitis, Necrotizing Vasculitis, Sjogren Syndrome, and Vasculitis.

Dr. Brit Adler is an Assistant Professor of Medicine in the Division of Rheumatology at Johns Hopkins University. She is building a career as a translational physician-scientist with a focus on Postural Orthostatic Tachycardia Syndrome (POTS) and infection-associated chronic illnesses. Her interest in this area emerged from her work in general rheumatology, where she frequently encountered patients with POTS, an often-overlooked and understudied condition. She is particularly interested in investigating the immune dysregulation underlying POTS, Long COVID, and Chronic Lyme Disease. By leveraging her prior experience in autoantibody discovery in rheumatic diseases, Dr. Adler aims to deepen our understanding of these conditions. In addition to her work in general rheumatology, Dr. Adler leads a dedicated POTS clinic and evaluates patients in the Hopkins Autonomic Lab, furthering her commitment to improving care for patients with autonomic disorders. She earned her medical degree from Case Western Reserve University in Cleveland, Ohio, and completed her residency in Internal Medicine at the Hospital of the University of Pennsylvania. Following this, she pursued a clinical and research fellowship in Rheumatology at Johns Hopkins. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Adler is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Polymyositis, Myositis, and Inclusion Body Myositis. Dr. Adler is board certified in American Board Of Internal Medicine.

Dr. Clifton Bingham is a Professor of Medicine, Director of the Johns Hopkins Arthritis Center, Director of the Center for Patient-Centered Outcomes Research in Rheumatology, Deputy Director for Research in the Division of Rheumatology, and Co-Director of the Rheumatic Diseases Research Core Center. He received his M.D. from Columbia University, where he also completed his Internal Medicine residency. He trained as a Fellow in both Rheumatology and in Allergy and Clinical Immunology at the Brigham and Women’s Hospital. Before coming to Hopkins in 2005, he was on faculty at NYU Hospital for Joint Diseases, where he founded a pioneering clinical and translational research center in rheumatology. He now directs the Johns Hopkins Arthritis Center, a group of 8 rheumatologists, 2 nurses, and a large clinical and research staff that sees more than 4500 patient visits each year, an integrates research with clinical care. His clinical interests are in the care of people living with Rheumatoid Arthritis (RA) and other forms of inflammatory arthritis. Dr. Bingham’s research experience has been diverse, and across the research continuum from bench to bedside. His early work focused on understanding the cytokine regulation of inflammatory mediator generation operative in rheumatologic and allergic diseases. He conducted prior translational research to better understand the role of initiating and amplifying pathways in RA, and has ongoing collaborations with several basic researchers to identify biomarkers for improved patient phenotyping and outcome prediction. Additional multidisciplinary clinical and translational work has focused on the role of periodontal disease and oral bacteria as triggers of RA. In the realm of clinical research, he has served as principal investigator and helped to design and analyze a number of NIH and industry-sponsored clinical trials of multiple agents in early to late phases of development for RA, psoriatic arthritis, and osteoarthritis. He has led several studies of the effects of biological and immunomodulatory therapies on responses to immunizations. A large amount of his current research is focused in the area of patient centered outcomes research, including patient reported outcome development, validation, and integration in clinical care. He serves as a member of the Executive Leadership Committee for the international Outcome Measures in Rheumatology (OMERACT) methodology group. He has authored more than 170 original research articles, reviews, and editorials, and 12 book chapters. He served as a Co-Editor for the journal of the American College of Rheumatology, Arthritis and Rheumatology, and as a reviewer for a number of rheumatology journals and national and international grant reviews. Dr. Bingham is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Myositis, and Psoriatic Arthritis. Dr. Bingham is board certified in American Board Of Internal Medicine.

Dr. Laura Cappelli is an Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and adverse effects from cancer immunotherapy. Dr. Cappelli earned her M.D. from Johns Hopkins. She completed her residency in internal medicine and performed a fellowship in rheumatology at the Johns Hopkins Hospital. She has a MHS in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Cappelli focuses on immune related adverse events due to cancer immunotherapy and all forms of inflammatory arthritis. She co-directs the Immune-related toxicity team which provides clinical, research and educational support for immune related adverse events. Her primary research interest is inflammatory arthritis due to immune checkpoint inhibitor therapy. She also studies rheumatoid arthritis. Dr. Cappelli is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Arthritis, Rheumatoid Arthritis (RA), Polymyalgia Rheumatica, and Rhizomelic Pseudopolyarthritis. Dr. Cappelli is board certified in American Board Of Internal Medicine.

Dr. Albayda is an Associate Professor of Medicine in the Division of Rheumatology. She is the Director of the Rheumatology Fellowship Program, as well as Director of the Musculoskeletal Ultrasound and Injection Clinic. Nationally, she is involved in MSK Ultrasound education and has expertise in arthritis and inflammatory myopathies. Her research focuses on imaging biomarkers in rheumatic diseases, developing muscle ultrasound, clinical phenotypes in myositis, as well as longitudinal care and therapeutics in inclusion body myositis. Dr. Albayda is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Pallister-Killian Mosaic Syndrome, Temple Syndrome, and Inclusion Body Myositis. Dr. Albayda is board certified in American Board Of Internal Medicine.

Dr. Homa Timlin is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include systemic lupus erythematosus, and lupus nephritis. Dr. Timlin serves on the faculty of the Johns Hopkins Consultative Rheumatology Clinic. A member of the Royal College of Physicians, Dr. Timlin earned her medical degree at Romania’s Universitatea de Medicana Si Farmacie Carol Davila. Upon completion of rheumatology fellowships, Oxford in the United Kingdom and an internal medicine residency in the United States, she joined the Johns Hopkins Lupus Center in 2011. After a one-year postdoctoral lupus fellowship under the mentorship of Dr. Michelle Petri, she finished her post-doctoral fellowship in rheumatology at Johns Hopkins. She also holds a master’s degree in clinical immunology (London University), MRCP diploma (Member of the Royal College of Physicians), Certificate of Completion of Specialty Training (CCST). Dr. Timlin has been an active educator who works with trainees at all levels, nationally and internationally, in the inpatient and outpatient settings. Presently, Dr. Timlin has established a retrospective cohort of several hundred patients with lupus and lupus nephritis, and site lead at the Johns Hopkins Bayview Medical Center. Dr. Timlin is the medical chair for the local chapter of Lupus Foundation of America (LFA) and the director of an IRB-approved prospective human diagnostic study using magnetic resonance imaging (MRI) to evaluate lupus nephritis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Timlin is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Discoid Lupus Erythematosus (DLE), and Cutaneous Lupus Erythematosus (CLE). Dr. Timlin is board certified in American Board Of Internal Medicine.